HAT-SIL-TG-1&AT
HAT-SIL-TG-1&AT is a hypoxia-activated prodrug that acts as a Janus kinase (JAK) inhibitor. It exerts antitumor effects by blocking the JAK-STAT pathway, suppressing HEL cell proliferation and reducing phospho-STAT3/5 levels under hypoxia, making it a tool for studying hypoxia-targeted oncology research.
Product Specifications
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Molecular Formula
C60H69N17O11S
Molecular Weight
1236.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV726137 1.0 µg DNA
FRA19A Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
MBS9359606 Inquire
Goat Protein Sprouty Homolog 4 (SPRY4) ELISA Kit
Sign In for Pricing
View Details AMM19085V 100 µL
Myotilin (MYOT) Mouse Monoclonal Antibody [Clone ID: LBI8A7]
Sign In for Pricing
View Details